Cyclin D2-cyclin-dependent kinase 4/6 is required for efficient proliferation and tumorigenesis following Apc loss

Alicia M Cole1, Kevin Myant, Karen R Reed

  • 1Beatson Institute of Cancer Research, Glasgow, United Kingdom; School of Biosciences, Cardiff, United Kingdom.

Cancer Research
|August 26, 2010
PubMed

Insights

Apc gene inactivation triggers colorectal cancer (CRC) by activating Wnt signaling. Cyclin D2, not cyclin D1, drives proliferation after Apc loss, offering a potential therapeutic target for CRC prevention.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gastroenterology

Background:

  • Apc gene inactivation is a critical early step in sporadic colorectal cancer (CRC) development.
  • Loss of Apc leads to constitutive Wnt signaling activation, promoting transcription of target genes like c-Myc.
  • While cyclin D1 is necessary for adenoma formation, its delayed upregulation post-Apc loss suggests involvement of other D-type cyclins in intestinal proliferation.

Purpose of the Study:

  • To investigate the expression and functional significance of cyclin D2 in the intestinal epithelium following Apc loss.
  • To determine if cyclin D2 plays a role in the immediate proliferative response to acute Apc loss.
  • To evaluate cyclin D2 as a potential therapeutic target for colorectal cancer.

Main Methods:

  • Investigated cyclin D2 expression in the intestinal epithelium after Apc loss.
  • Assessed the impact of cyclin D2 deficiency on enterocyte proliferation and crypt size in Apc-deficient models.
  • Evaluated the effect of cyclin D2 on tumor growth and development in Apc(Min/+) mice.
  • Examined the impact of CDK4/6 inhibition on normal and adenomatous cells from Apc(Min/+) mice.

Main Results:

  • Cyclin D2 is upregulated immediately following Apc loss, coinciding with increased cyclin-dependent kinase 4 (CDK4) and hyperphosphorylated Rb levels.
  • Cyclin D2 deficiency reduced enterocyte proliferation and crypt size in Apc-deficient intestines.
  • Cyclin D2 deficiency significantly inhibited tumor growth and development in Apc(Min/+) mice.
  • CDK4/6 inhibition suppressed proliferation of adenomatous cells but not normal enterocytes in Apc(Min/+) mice.

Conclusions:

  • Cyclin D-CDK4/6 complexes are essential for the proliferation of cells with deregulated Wnt signaling.
  • Targeting the cyclin D-CDK4/6 complex represents a promising chemopreventative strategy for colorectal cancer.
  • Cyclin D2 is a key mediator of proliferation following Apc loss in the intestinal epithelium.

Related Concept Videos

Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...